glp 1 drugs in development Navigating the -tides: Medication-Assisted Weight Loss on the Forefront Market Overview: GLP-1 Agonists and

It shows how these companies are using the patent system as a key tool to maximize revenues, profitability, and shareholder returns

However, neuronal ROS production was reduced, while astrocytic ROS levels increased, suggesting possible differential effects on mitochondrial function [85]

The sources for the data on these drugs are rather patchy, making direct comparisons difficult due to incomplete data

doi: 10.1016/j.obpill.2023.100080

In addition to the effect on food intake reduction and glucose-stimulated insulin secretion, GLP-1 also acts to delay gastric emptying therefore aiding satiety and glycaemic control (42)

Barale C, Buracco S, Cavalot F, et al